Semaglutide reduces appetite by activating GLP-1 receptors in your brain and slowing gastric emptying, which means your stomach processes food more slowly than before treatment
Patients who may particularly benefit from the oral option include: Those with needle concerns: While modern GLP-1 injections use very small needles, some patients have significant needle phobia that prevents them from starting treatment Patients seeking a less medical approach: Some individuals prefer the familiarity of taking a daily pill over self-injecting Weight maintenance candidates: Emerging research suggests oral GLP-1s may be effective for maintaining weight loss after achieving goals on injectable medications Those with access challenges: Pills dont require refrigeration and may be easier to travel with Important Considerations Before Switching or Starting The Wegovy pill will be available in January 2026, with the starting 1.5mg dose priced at $149 per month for cash-paying patients

The L-Arginine paradox is a well-documented scientific puzzle: In published studies at researched doses, L-Arginine supplementation has sometimes been shown to improve blood flow and lower blood pressure even though normal plasma L-Arginine levels already exceed the concentration the eNOS enzyme needs to produce nitric oxide - a finding that researchers describe as the "L-Arginine paradox." You'd expect extra L-Arginine to have no effect - but it often does
Sex steroid hormones matter for learning and memory: estrogenic regulation of hippocampal function in male and female rodents
Your risk of hypoglycemia can increase if youre simultaneously taking a GLP-1 medication and another drug (like a sulfonylureas medication or insulin) to lower your blood sugar
Slowed gastric emptying can lead to a slower rise in blood alcohol, as alcohol is not well absorbed in the stomach